YOLFTbeta
17

Apex Biotechnology Corp

1733 · TW · Healthcare / Medical Devices

29.20TWD+0.70 (+2.46%)

Price History

Full chart

Market Stats

Previous Close28.50
Open28.55
Day Range28.50 – 30.00
52-Week Range28.00 – 38.70
Volume161.11K
Market Cap2.98B
P/E (TTM)15.71
Forward P/E12.32
EPS1.90
Dividend Yield4.39%
Beta0.26
50-Day Avg31.30
200-Day Avg30.15

About

Apex Biotechnology Corp. researches, develops, manufactures, and sells home care medical devices by using biosensor technology worldwide. It offers blood glucose, uric acid, hemoglobin, cholesterol, lactate, HbA1C, and ketone monitoring systems, as well as coagulation and multifunctional self-testing systems. The company also provides pesticide residue check systems; and care management and tele-health services. The company was incorporated in 1997 and is headquartered in Hsinchu City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEODr. Yanshi Shen Ph.D.
  • Employees0
  • HeadquartersNo. 7, Li-Hsin 5th Road, Hsinchu City, Taiwan, 30078, Taiwan
  • Websitehttps://www.apexbio.com

Leadership

  • Dr. Yanshi Shen Ph.D.Chairman, CEO & GM
  • Yingxiang ChuCFO & Accounting Supervisor
  • Chun Hui WuVice President of Administration & Spokesman
  • Yanshi ShenVice President of Marketing & Sales
  • Mr. Meng Wen YangDirector

Financials

Income Statement

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue446.70M603.62M619.97M841.70M1.03B1.13B1.19B1.44B1.75B1.88B2.03B1.83B1.79B1.85B1.76B1.80B2.04B2.20B2.01B2.13B2.24B1.68B1.85B1.94B
Growth (%)-+35.13%+2.71%+35.77%+22.42%+9.81%+5.40%+20.67%+21.60%+7.23%+7.98%-9.72%-2.20%+3.27%-4.56%+1.82%+13.83%+7.60%-8.80%+6.30%+5.28%-25.29%+10.48%+5.00%
Cost of Revenue225.98M282.88M274.00M444.27M511.29M508.96M613.52M826.47M995.81M1.13B1.22B1.26B1.26B1.30B1.29B1.36B1.48B1.61B1.55B1.56B1.67B1.15B1.33B1.41B
Gross Profit-------612.44M753.88M749.21M808.36M568.44M524.67M547.13M476.84M431.51M560.10M590.58M452.22M571.51M576.84M531.12M521.34M538.74M
Gross Margin-------42.56%43.09%39.93%39.90%31.08%29.33%29.62%27.04%24.04%27.41%26.86%22.55%26.81%25.70%31.68%28.15%27.70%
Operating Expense-------162.98M179.85M191.57M205.77M219.45M235.19M246.34M230.95M270.51M332.75M417.67M331.70M377.54M371.87M389.40M392.83M398.01M
Operating Income78.26M158.42M144.82M140.16M321.81M452.63M360.85M449.46M574.02M557.64M602.60M348.99M289.49M300.80M245.89M161.00M227.35M172.91M120.53M193.97M204.97M141.72M128.51M140.73M
Operating Margin17.52%26.24%23.36%16.65%31.23%40.01%30.26%31.24%32.81%29.72%29.74%19.08%16.18%16.28%13.94%8.97%11.12%7.86%6.01%9.10%9.13%8.45%6.94%7.24%
EBITDA-------489.10M603.23M679.58M687.15M550.93M441.47M434.40M163.45M230.89M278.35M289.10M225.73M289.65M299.07M221.06M221.58M201.65M
EBITDA Margin-------33.99%34.48%36.22%33.92%30.12%24.68%23.51%9.27%12.86%13.62%13.15%11.26%13.59%13.33%13.19%11.96%10.37%
Net Income100.74M161.60M165.49M-304.41M402.53M284.29M326.48M453.95M526.62M522.71M371.22M273.38M261.85M3.18M85.55M95.12M113.86M94.80M202.22M181.78M115.78M128.00M163.04M
Net Income Margin22.55%26.77%26.69%-29.54%35.58%23.84%22.69%25.94%28.07%25.80%20.29%15.28%14.17%0.18%4.77%4.65%5.18%4.73%9.49%8.10%6.91%6.91%8.38%
R&D61.08M58.88M61.00M61.87M56.20M51.59M57.81M65.69M82.46M88.39M98.23M109.15M105.03M102.18M93.04M101.26M116.38M155.12M150.77M153.29M165.45M163.32M161.52M147.30M
R&D as % of Total Revenue13.67%9.75%9.84%7.35%5.45%4.56%4.85%4.57%4.71%4.71%4.85%5.97%5.87%5.53%5.28%5.64%5.69%7.05%7.52%7.19%7.37%9.74%8.72%7.57%
Interest Expense00000000168.00K45.00K2.85M6.04M7.69M10.35M8.15M9.18M11.12M9.63M10.28M12.53M5.40M4.39M3.64M3.39M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.00%0.14%0.33%0.43%0.56%0.46%0.51%0.54%0.44%0.51%0.59%0.24%0.26%0.20%0.17%

Balance Sheet

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets801.97M964.43M994.56M1.12B1.30B1.55B1.49B1.77B1.95B2.14B2.75B2.72B2.64B2.69B2.50B2.70B2.55B2.81B2.65B2.67B2.51B2.30B2.42B2.42B
Total Liabilities89.21M122.00M128.64M223.36M195.73M204.80M221.21M303.31M320.60M388.76M735.18M803.47M778.52M764.69M768.49M1.03B901.70M1.14B1.01B916.91M696.81M500.07M595.70M545.32M
Total Equity712.76M836.82M865.91M890.39M1.10B1.35B1.26B1.47B1.63B1.75B2.01B1.92B1.87B1.93B1.73B1.66B1.64B1.68B1.65B1.75B1.82B1.80B1.82B1.87B
Cash12.33M32.94M191.46M217.24M155.97M299.94M398.77M244.51M583.49M372.76M587.19M319.50M217.77M491.90M579.21M622.55M318.19M653.70M786.95M555.33M331.70M382.05M532.68M567.09M
Total Debt-------111.86M62.87M62.55M423.15M447.94M441.98M405.41M415.07M652.22M479.11M667.25M571.80M343.28M243.91M180.83M166.16M148.86M
Net Debt--------132.65M-520.62M-310.22M-164.05M128.44M224.20M-86.49M-164.14M29.67M160.92M13.55M-215.14M-212.06M-87.80M-201.22M-366.52M-418.23M

Cash Flow

Currency: TWD2002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow79.49M302.25M218.54M212.14M363.71M364.62M299.96M391.29M465.59M273.45M509.67M484.77M267.60M472.15M298.06M70.83M67.57M462.52M280.60M179.87M26.62M230.39M328.67M164.14M
Investing Cash Flow--74.60M---165.05M-420.94M169.54M-82.95M-417.88M-291.71M-34.35M40.08M17.57M-85.03M-45.34M-132.83M78.83M-35.02M-41.37M-22.50M-35.60M-5.54M
Financing Cash Flow--------124.61M-296.15M-401.23M122.72M-443.38M-325.15M-251.31M-223.29M79.22M-344.94M6.73M-224.85M-351.27M-237.60M-168.14M-148.67M-132.68M
Capital Expenditure61.13M56.21M251.16M81.30M41.99M54.71M129.74M73.34M161.05M74.63M414.70M247.69M65.41M26.66M38.45M26.76M75.29M56.58M48.32M26.20M40.20M24.98M29.63M15.26M
Free Cash Flow-------317.95M304.53M198.82M94.96M237.08M202.19M445.49M259.60M44.07M-7.72M405.94M232.28M153.67M-13.58M205.41M299.04M148.88M
Dividends Paid-34.21M53.89M137.13M134.39M173.46M332.28M124.61M296.15M401.23M476.70M443.39M325.15M246.33M223.40M149.59M149.59M84.74M109.94M109.31M129.94M139.93M109.94M119.94M
FCF to OCF-------81.26%65.41%72.71%18.63%48.91%75.56%94.35%87.10%62.22%-11.43%87.77%82.78%85.43%-51.04%89.16%90.98%90.70%
Dividend Paid to FCF-------39.19%97.25%201.81%501.99%187.02%160.82%55.29%86.05%339.45%-1937.19%20.87%47.33%71.14%-956.53%68.12%36.77%80.56%

Earnings

Report DateJul 11, 2007Oct 26, 2007Jan 30, 2008Apr 28, 2008Oct 28, 2008Apr 29, 2009Sep 2, 2009Oct 28, 2009Mar 3, 2010Apr 15, 2010Jul 15, 2010Oct 28, 2010Mar 27, 2011Jun 1, 2011Aug 29, 2011Nov 30, 2011Jan 15, 2012Apr 30, 2012Aug 24, 2012Nov 28, 2012Mar 22, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 11, 2014Aug 13, 2014Nov 13, 2014Mar 31, 2015May 13, 2015Aug 13, 2015Nov 11, 2015Mar 30, 2016May 14, 2016Aug 9, 2016Nov 8, 2016Mar 1, 2017Apr 3, 2017Aug 9, 2017Nov 10, 2017Mar 29, 2018May 15, 2018Aug 13, 2018Nov 11, 2018Mar 26, 2019May 13, 2019Aug 13, 2019Nov 7, 2019Mar 26, 2020May 12, 2020Aug 12, 2020Nov 10, 2020Mar 26, 2021May 12, 2021Aug 10, 2021Nov 10, 2021Mar 23, 2022May 11, 2022Aug 9, 2022Nov 9, 2022Mar 10, 2023May 9, 2023Aug 8, 2023Aug 11, 2024Nov 13, 2024Feb 26, 2025Nov 7, 2025
EPS Estimate1.081.211.300.790.990.89-0.88-1.211.301.361.41-1.24-1.431.401.50-1.29----0.640.900.700.800.760.82-0.870.700.690.81--0.320.290.37-0.420.50-0.400.330.470.320.760.43--------0.500.51---0.060.200.501.70
EPS Actual0.941.481.000.531.040.870.610.801.111.121.301.360.941.011.151.801.501.521.511.101.211.221.560.510.300.610.630.610.830.360.401.020.720.640.620.01-1.31-0.390.550.220.440.170.410.63-0.320.200.26-0.170.720.110.250.210.300.310.210.640.790.450.290.640.430.360.270.270.330.380.22
Surprise-12.96%22.31%-23.08%-32.91%5.05%-2.25%--9.09%--7.44%0.00%0.00%-33.33%--7.26%-4.90%8.57%0.67%--6.20%-----4.69%-30.00%-12.86%3.75%-52.63%-51.22%--17.24%-8.57%-10.14%-98.77%--71.88%-24.14%18.92%--2.38%26.00%20.00%-39.39%-44.68%-153.13%-5.26%-74.42%---------42.00%25.49%---350.00%65.00%-24.00%-87.06%
TimingPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-After-hours-After-hoursAfter-hoursPre-marketAfter-hours-Pre-market-After-hoursPre-marketAfter-hours-After-hours----After-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketAfter-hours-Pre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market

Key Statistics & Ratios

Market Cap2.98B
Enterprise Value2.33B
Trailing P/E15.71
Forward P/E12.32
PEG Ratio0.00
Price / Sales1.60
Price / Book1.62
EPS1.90
Book Value18.60
Revenue (TTM)1.87B
Gross Profit (TTM)573.13M
EBITDA221.12M
Profit Margin10.19%
Operating Margin9.48%
Return on Equity10.44%
Return on Assets4.37%
Shares Outstanding99.95M
Shares Float60.20M
Beta0.26
Dividend Yield4.39%
Dividend Rate1.30
Payout Ratio68.38%

Dividends

20231×
1.40Jun 15, 2023
20221×
1.30Jun 16, 2022
20211×
0.90Aug 17, 2021
20201×
1.11Jul 1, 2020
20191×
0.85Jul 1, 2019
20181×
0.75Jul 4, 2018
20171×
0.32Jun 29, 2017
20161×
2.24Jun 30, 2016
20151×
2.50Jul 21, 2015
20141×
3.30Jul 24, 2014
20131×
4.50Jun 13, 2013
20121×
4.97May 24, 2012
20111×
4.19Jun 10, 2011
20101×
3.09Jun 10, 2010
20091×
1.50Jul 1, 2009
20081×
3.47Aug 6, 2008
20071×
2.03Jul 19, 2007
20061×
1.54Jun 14, 2006
20051×
1.53Jun 2, 2005
20041×
0.67Jul 14, 2004
20031×
0.41Jul 17, 2003

Stock Splits

  • Aug 31, 2012964:961
  • Jul 1, 200923:20
  • Jul 19, 200711:10
  • Jun 14, 20061340:1301
  • Jul 14, 2004581:500
  • Jul 17, 2003287:250
  • Jul 4, 2002131:100
  • Aug 9, 2001131:100